Sell Benchling Stock"

2012
HealthTech
$424.97M
www.benchling.com

Investors Include:

Tiger Global ManagementBenchmarkFounders FundAndreessen HorowitzSequoia Capital

Further Key Investors:

Draper Associates, Rogue Capital, Benchmark (San Francisco), ICONIQ Growth, Rock Health Capital, Elad Gil, Y Combinator, Lone Pine Capital, Ashton Kutcher, Artisanal Ventures, Lux Capital, Carnegie VC, Spark Capital, Matt Huang, Christopher Golda, Michael Montano, Thrive Capital, Adam Draper, Eight Roads, F-Prime Capital, Foreword, Ensemble Labs, Menlo Ventures, Byers Capital, Alkeon Capital Management.

Draper Associates, Rogue Capital, Benchmark (San Francisco), ICONIQ Growth, Rock Health Capital, Elad Gil, Y Combinator, Lone Pine Capital, Ashton Kutcher, Artisanal Ventures, Lux Capital, Carnegie VC, Spark Capital, Matt Huang, Christopher Golda, Michael Montano, Thrive Capital, Adam Draper, Eight Roads, F-Prime Capital, Foreword, Ensemble Labs, Menlo Ventures, Byers Capital, Alkeon Capital Management, Geoff Ralston, David Wallerstein, Kevin Mahaffey, Altimeter Capital Management, Hawktail, Lead Edge Capital, Franklin Venture Partners, SV Angel.

Benchling is a cloud-based platform specifically designed for biotechnology research and development. With its comprehensive R&D Cloud, Benchling empowers scientists to expedite the entire research and development lifecycle. The R&D Cloud encompasses data management, collaboration tools, and valuable insights, all built on a reliable and open cloud platform. By leveraging Benchling, scientists can streamline their workflows, enhance collaboration, and gain valuable insights for their biotech projects.

Management Team
Sajith Wickramasekara
Ashutosh Singhal
Richard Wong
Stephen Deasy
Zach Powers
Lindsey Irvine
Niall Wall
Shawna Wolverton
Board Members
Ashutosh Singhal
Eric Vishria
Jennifer Goldsmith
Krista Anderson-Copperman
Miles Grimshaw
Ron Gill
Sajith Wickramasekara
William J.G. Griffith
News
PRNewswire

Benchling Creates Open Source Library of Lab Instrument Data Converters

Benchling partners with Allotrope, backing industry standards and making library of open source industry data converters freely available to the scientific community SAN FRANCISCO, May 16, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnolo…

Scientific Computing

Solution Accelerators for biotech research

Benchling has announced new products and services focused on driving long-term success in the modern R&D lab

Yahoo Finance

Life sciences software startup Benchling lays off 9% of workforce

The startup joins a growing number of U.S. firms, including Facebook-parent Meta Platforms Inc, Amazon.com Inc and several startups, to downsize its workforce

Yahoo Finance

Benchling Bolsters Success Offerings for Biotech R&D With New Purpose-Built Solutions, Training, and Expert Services

Benchling, the R&D Cloud powering the biotechnology industry, today announced new products and services focused on driving long-term success in the modern R&D lab.

PRNewswire

Benchling Bolsters Commitment to Security with Type 2 SOC 2

Rigorous examination confirms Benchling offers best-in-class security to protect its global biotech customer base SAN FRANCISCO, Jan. 26, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnology industry, announced it has successfully complete…

PRN Newswire

Benchling Announces New Executive Appointments and 1,000 Customer Milestone

Benchling, the R&D Cloud powering the biotechnology industry, announced the appointment of new executive leadership to its engineering and field organizations. These hires come at the same time the company achieved significant financial milestones. In the first half of its fiscal year, Benchling surpassed 1,000 customers and increased subscription revenue 90% year-over-year. Dollar-based net expansion was greater than 150%, indicative of customers rapidly growing their use of the R&D Cloud.